Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Joseph J. Boland"'
Autor:
Charlene Caid, Melissa O. West, Jeanne M. Devine, Robert F. Sabalis, Edward Davidson, H.R. Nankin, Joseph J. Boland, Richard J. Milan, Peter R. Kilmann
Publikováno v:
Journal of Sex Education and Therapy. 14:46-49
Using the Sexual Interaction Inventory (SII), the scores of 21 couples in which the men had secondary erectile dysfunction were contrasted with those of 63 “sexually satisfied” couples. Significant differences between the two samples were found o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06af3c36397952d0dae96c3088176cba
https://doi.org/10.1080/01614576.1988.11074924
https://doi.org/10.1080/01614576.1988.11074924
Autor:
Hardaker EL; Oncology R&D, AstraZeneca, Cambridge, UK., Sanseviero E; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Karmokar A; Oncology R&D, AstraZeneca, Cambridge, UK., Taylor D; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Milo M; Oncology R&D, AstraZeneca, Cambridge, UK., Michaloglou C; Oncology R&D, AstraZeneca, Cambridge, UK., Hughes A; Oncology R&D, AstraZeneca, Cambridge, UK., Mai M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., King M; Oncology R&D, AstraZeneca, Cambridge, UK., Solanki A; Oncology R&D, AstraZeneca, Cambridge, UK., Magiera L; Oncology R&D, AstraZeneca, Cambridge, UK., Miragaia R; Oncology R&D, AstraZeneca, Cambridge, UK., Kar G; Oncology R&D, AstraZeneca, Cambridge, UK., Standifer N; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Tempest Therapeutics, Brisbane, CA, USA., Surace M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Gill S; Oncology R&D, AstraZeneca, Cambridge, UK., Peter A; Oncology R&D, AstraZeneca, Cambridge, UK., Talbot S; Oncology R&D, AstraZeneca, Cambridge, UK., Tohumeken S; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Fryer H; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Mostafa A; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Mulgrew K; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Lam C; Oncology R&D, AstraZeneca, Cambridge, UK., Hoffmann S; Imaging and Data Analytics, AstraZeneca, Cambridge, UK., Sutton D; Imaging and Data Analytics, AstraZeneca, Cambridge, UK., Carnevalli L; Oncology R&D, AstraZeneca, Cambridge, UK., Calero-Nieto FJ; Oncology R&D, AstraZeneca, Cambridge, UK., Jones GN; Oncology R&D, AstraZeneca, Cambridge, UK., Pierce AJ; Oncology R&D, AstraZeneca, Cambridge, UK.; Crescendo Biologics Limited, Cambridge, UK., Wilson Z; Oncology R&D, AstraZeneca, Cambridge, UK., Campbell D; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Nyoni L; Oncology R&D, AstraZeneca, Cambridge, UK., Martins CP; Oncology R&D, AstraZeneca, Cambridge, UK., Baker T; CPSS AST, AstraZeneca, Cambridge, UK., Serrano de Almeida G; CPSS AST, AstraZeneca, Cambridge, UK., Ramlaoui Z; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Bidar A; CPSS, Imaging, AstraZeneca, Gothenburg, Sweden., Phillips B; Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Boland J; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Iyer S; Oncology R&D, AstraZeneca, Boston, MA, USA., Barrett JC; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Loembé AB; Early Clinical Development, AstraZeneca, Oss, the Netherlands., Fuchs SY; Department of Biomedical Sciences, School of Veterinary Medicine University of Pennsylvania, Philadelphia, PA, 19104, USA., Duvvuri U; UPMC Department of Otolaryngology and UPMC Hillman Cancer Center, 200 Lothrop St. Suite 500, Pittsburg, PA, 15213, USA., Lou PJ; National Taiwan University Hospital, No. 7, Chung Shan S. Rd. (Zhongshan S. Rd.), Zhongzheng Dist., Taipei City, 10002, Taiwan., Nance MA; VA Pittsburgh Healthcare System, University Drive C, Pittsburg, PA, 15240, USA., Gomez Roca CA; Institut Claudius Regaud-Cancer Comprehensive Center, 1 Avenue Irene Joliot-Curie, IUCT-O, Toulouse, 31059 Cedex 9, France., Cadogan E; Oncology R&D, AstraZeneca, Cambridge, UK., Critichlow SE; Oncology R&D, AstraZeneca, Cambridge, UK., Fawell S; Oncology R&D, AstraZeneca, Boston, MA, USA., Cobbold M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Dean E; Oncology R&D, AstraZeneca, Cambridge, UK., Valge-Archer V; Oncology R&D, AstraZeneca, Cambridge, UK., Lau A; Oncology R&D, AstraZeneca, Cambridge, UK., Gabrilovich DI; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA. dmitry.gabrilovich@astrazeneca.com., Barry ST; Oncology R&D, AstraZeneca, Cambridge, UK. simon.t.barry@astrazeneca.com.
Publikováno v:
Nature communications [Nat Commun] 2024 Feb 24; Vol. 15 (1), pp. 1700. Date of Electronic Publication: 2024 Feb 24.
Autor:
Clarke MA; Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, Maryland, USA., Risley C; Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, Maryland, USA.; School of Nursing, University of Mississippi Medical Center, Jackson, Mississippi, USA., Stewart MW; School of Nursing, University of Mississippi Medical Center, Jackson, Mississippi, USA., Geisinger KR; Walter Reed National Military Medical Center, Armed Forces Joint Pathology Center, Bethesda, Maryland, USA., Hiser LM; School of Nursing, University of Mississippi Medical Center, Jackson, Mississippi, USA., Morgan JC; School of Nursing, University of Mississippi Medical Center, Jackson, Mississippi, USA., Owens KJ; School of Nursing, University of Mississippi Medical Center, Jackson, Mississippi, USA.; Center for Informatics & Analytics, University of Mississippi Medical Center, Jackson, Mississippi, USA., Ayyalasomayajula K; School of Nursing, University of Mississippi Medical Center, Jackson, Mississippi, USA.; Center for Informatics & Analytics, University of Mississippi Medical Center, Jackson, Mississippi, USA., Rives RM; School of Nursing, University of Mississippi Medical Center, Jackson, Mississippi, USA.; Department of Pathology, University of Mississippi Medical Center, Jackson, Mississippi, USA., Jannela A; School of Nursing, University of Mississippi Medical Center, Jackson, Mississippi, USA.; Center for Informatics & Analytics, University of Mississippi Medical Center, Jackson, Mississippi, USA., Grunes DE; Department of Pathology, University of Mississippi Medical Center, Jackson, Mississippi, USA., Zhang L; School of Nursing, University of Mississippi Medical Center, Jackson, Mississippi, USA.; Office of Health Data & Research, Mississippi State Department of Health, Jackson, Mississippi, USA., Schiffman M; Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, Maryland, USA., Wagner S; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland, USA., Boland J; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland, USA., Bass S; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland, USA., Wentzensen N; Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, Maryland, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2021 Dec; Vol. 10 (23), pp. 8641-8650. Date of Electronic Publication: 2021 Nov 03.
Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphoma.
Autor:
Mahale P; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Nomburg J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Song JY; Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA., Steinberg M; Cancer Genomics Research Laboratory, National Cancer Institute, Rockville, MD, USA., Starrett G; Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Boland J; Cancer Genomics Research Laboratory, National Cancer Institute, Rockville, MD, USA., Lynch CF; Department of Epidemiology, The University of Iowa College of Public Health, Iowa City, Iowa, USA., Chadburn A; Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA., Rubinstein PG; Stroger Hospital of Cook County, Ruth M. Rothstein Core Center, Rush University Medical Center, Chicago, IL, USA., Hernandez BY; University of Hawaii Cancer Center, Honolulu, HI, USA., Weisenburger DD; Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA., Bullman S; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Engels EA; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. engelse@exchange.nih.gov.
Publikováno v:
Infectious agents and cancer [Infect Agent Cancer] 2021 Nov 14; Vol. 16 (1), pp. 65. Date of Electronic Publication: 2021 Nov 14.
Autor:
Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Tsang SH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Hu S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Porras C; Agencia Costarricense de Investigaciones Biomédicas, formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Herrero R; Agencia Costarricense de Investigaciones Biomédicas, formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica.; Prevention and Implementation Group, International Agency for Research on Cancer, Lyon, France., Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Schussler J; Information Management Services, Silver Spring, Maryland, USA., Boland J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc, Frederick, Maryland, USA., Wagner S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc, Frederick, Maryland, USA., Cortes B; Agencia Costarricense de Investigaciones Biomédicas, formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Rodríguez AC; Independent Consultant, San José, Costa Rica., Quint W; DDL Diagnostic Laboratory, Rijswijk, The Netherlands., van Doorn LJ; DDL Diagnostic Laboratory, Rijswijk, The Netherlands., Schiffman M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Hildesheim A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2021 Aug 02; Vol. 224 (3), pp. 503-516.
Autor:
Porras C; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA, San José, Costa Rica. Electronic address: cporras@acibcr.com., Tsang SH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA., Herrero R; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA, San José, Costa Rica; Early Detection and Prevention Section, International Agency for Research on Cancer, World Health Organization, Lyon, France., Guillén D; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA, San José, Costa Rica., Darragh TM; University of California, San Francisco, San Francisco, CA, USA., Stoler MH; Department of Pathology, University of Virginia, Charlottesville, VA, USA., Hildesheim A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA., Wagner S; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA., Boland J; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA., Lowy DR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA., Schiller JT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA., Schiffman M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA., Schussler J; Information Management Services, Calverton, MD, USA., Gail MH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA., Quint W; DDL Diagnostic Laboratory, Rijswijk, Netherlands., Ocampo R; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA, San José, Costa Rica., Morales J; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA, San José, Costa Rica., Rodríguez AC; San José, Costa Rica., Hu S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA., Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA., Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2020 Dec; Vol. 21 (12), pp. 1643-1652.
Autor:
Tsang SH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Schussler J; Information Management Services, Silver Spring, MD, USA., Porras C; Agencia Costarricense de Investigaciones Biomédicas, formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Wagner S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc, Frederick, MD, USA., Boland J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc, Frederick, MD, USA., Cortes B; Agencia Costarricense de Investigaciones Biomédicas, formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Lowy DR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Schiller JT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Schiffman M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kemp TJ; HPV Immunology Laboratory, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Rodriguez AC; Independent Consultant, San José, Costa Rica., Quint W; DDL Diagnostic Laboratory, Rijswijk, The Netherlands., Gail MH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Pinto LA; HPV Immunology Laboratory, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Gonzalez P; Agencia Costarricense de Investigaciones Biomédicas, formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Hildesheim A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Herrero R; Agencia Costarricense de Investigaciones Biomédicas, formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica.; Early Detection and Prevention Section, International Agency for Research on Cancer, Lyon, France.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2020 Oct 01; Vol. 112 (10), pp. 1030-1037.
Autor:
Kreimer AR; National Cancer Institute, NIH, Bethesda, MD, USA., Sampson JN; National Cancer Institute, NIH, Bethesda, MD, USA., Porras C; Agencia Costarricense de Investigaciones Biomédicas (ACIB), Formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Schiller JT; National Cancer Institute, NIH, Bethesda, MD, USA., Kemp T; HPV Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Herrero R; Early Detection and Prevention Section, International Agency for Research on Cancer, Lyon, France., Wagner S; National Cancer Institute, NIH, Bethesda, MD, USA.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, USA., Boland J; National Cancer Institute, NIH, Bethesda, MD, USA.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, USA., Schussler J; Information Management Systems, Silver Spring, MD, USA., Lowy DR; National Cancer Institute, NIH, Bethesda, MD, USA., Chanock S; National Cancer Institute, NIH, Bethesda, MD, USA., Roberson D; National Cancer Institute, NIH, Bethesda, MD, USA.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, USA., Sierra MS; National Cancer Institute, NIH, Bethesda, MD, USA., Tsang SH; National Cancer Institute, NIH, Bethesda, MD, USA., Schiffman M; National Cancer Institute, NIH, Bethesda, MD, USA., Rodriguez AC; Independent Consultant, San José, Costa Rica., Cortes B; Agencia Costarricense de Investigaciones Biomédicas (ACIB), Formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Gail MH; National Cancer Institute, NIH, Bethesda, MD, USA., Hildesheim A; National Cancer Institute, NIH, Bethesda, MD, USA., Gonzalez P; Agencia Costarricense de Investigaciones Biomédicas (ACIB), Formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Pinto LA; HPV Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2020 Oct 01; Vol. 112 (10), pp. 1038-1046.
Autor:
Brodie SA, Rodriguez-Aulet JP, Giri N, Dai J, Steinberg M, J Waterfall J, Roberson D, Ballew BJ, Zhou W, Anzick SL, Jiang Y, Wang Y, Zhu YJ, Meltzer PS, Boland J, Alter BP, Savage SA
Publikováno v:
Cold Spring Harbor molecular case studies [Cold Spring Harb Mol Case Stud] 2020 Feb 03; Vol. 6 (1). Date of Electronic Publication: 2020 Feb 03 (Print Publication: 2020).
Autor:
Brodie SA; Cancer Genomics Research Laboratory, Leidos Biomedical Research, NCI-Frederick, Rockville, Maryland 20850, USA., Rodriguez-Aulet JP; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20859, USA., Giri N; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20859, USA., Dai J; Cancer Genomics Research Laboratory, Leidos Biomedical Research, NCI-Frederick, Rockville, Maryland 20850, USA., Steinberg M; Cancer Genomics Research Laboratory, Leidos Biomedical Research, NCI-Frederick, Rockville, Maryland 20850, USA., Waterfall JJ; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20859, USA., Roberson D; Cancer Genomics Research Laboratory, Leidos Biomedical Research, NCI-Frederick, Rockville, Maryland 20850, USA., Ballew BJ; Cancer Genomics Research Laboratory, Leidos Biomedical Research, NCI-Frederick, Rockville, Maryland 20850, USA., Zhou W; Cancer Genomics Research Laboratory, Leidos Biomedical Research, NCI-Frederick, Rockville, Maryland 20850, USA., Anzick SL; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20859, USA., Jiang Y; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20859, USA., Wang Y; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20859, USA., Zhu YJ; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20859, USA., Meltzer PS; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20859, USA., Boland J; Cancer Genomics Research Laboratory, Leidos Biomedical Research, NCI-Frederick, Rockville, Maryland 20850, USA., Alter BP; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20859, USA., Savage SA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20859, USA.
Publikováno v:
Cold Spring Harbor molecular case studies [Cold Spring Harb Mol Case Stud] 2019 Dec 13; Vol. 5 (6). Date of Electronic Publication: 2019 Dec 13 (Print Publication: 2019).